🔎 Trials Near Me

Home › Overweight › Florida › The Villages

Overweight clinical trials in The Villages, FL

8 studies for Overweight are looking for participants at sites in and around The Villages (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

RecruitingPhase 2
  • Charter Research - The Villages /ID# 282376, The Villages
Ages 18 to 75 · All sexes · Updated Oct 2, 2026 · NCT07752979

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

RecruitingPhase 2
  • Charter Research LLC - The Villages, The Villages
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07685808

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

RecruitingPhase 2
  • Charter Research - Lady Lake, The Villages
Ages 18 to 75 · All sexes · Updated Sep 22, 2026 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

RecruitingPhase 3
  • AURORA-1 Clinical Site, The Villages
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

RecruitingPhase 3
  • AURORA-2 Clinical Site, The Villages
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07743450

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

RecruitingPhase 2
  • Charter Research - Lady Lake, The Villages
Ages 18 to 75 · All sexes · Updated Sep 8, 2026 · NCT06143956

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

RecruitingPhase 3
  • Kailera Clinical Site, The Villages
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT07284901

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

RecruitingPhase 3
  • Charter Research - The Villages, The Villages
Ages 18 to 99 · All sexes · Updated Aug 27, 2026 · NCT07575399

Overweight trials in other cities

Other studies in The Villages

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.